Related Topics
     
    William L. Greene, PharmD

    William L. Greene, PharmD

    Member, St. Jude Faculty
    Chief Pharmaceutical Officer

    Departments

    Pharmaceutical Sciences
    Administration

    Contact Information

    William Greene, PharmD
    Pharmaceutical Sciences
    MS 150, Room BP024F
    St. Jude Children's Research Hospital
    262 Danny Thomas Place
    Memphis, TN 38105-3678
    Email: william.greene@stjude.org
    Phone: (901) 595-3686
    FAX: (901) 595-3111

    Education

    BS (Pharmacy) - University of North Carolina, Chapel Hill (1979)
    PharmD - University of Tennessee Center for Health Sciences, Memphis (1981)
    Residency – Hospital Pharmacy, Duke University Hospital/Medical Center (1982)


    Honors & Awards


    Research Interests


    Selected Publications

    AlFaar AS, Kamal S, AbouElnaga S, Greene WL, Quintana Y, Ribeiro RC, Qaddaoumi IA. International telepharmacy education: another venue to improve cancer care in the developing world. Telemedicine and e-Health Jul;18(6):470-4, 2012. Epub 2012 Jun 5, 2012.

    Lobo B, Greene WL. Comment: zolpidem: distinct from triazolam? (reply to letter) Annals of Pharmacotherapy 31:1410-13, 1997.

    Lobo B, Greene WL. Insomnia (zolpidem is not superior to triazolam. (letter) New Engl J Med 336:1919, 1997.

    Lobo B, Greene WL. Zolpidem: Distinct from triazolam? Annals of Pharmacotherapy 31:625-32, 1997.

    Simmons BP, Gelfand MS, Greene WL. Empiric use of amphotericin B and fluconazole for nosocomial fever of unknown origin not responding to antibacterial antibiotics. Infect Dis Clin Pract 6:177-81, 1997.

    Bertorini TE, Nance AM, Horner LH, Greene W, Gelfand MS, Jaster JH. Complications of intravenous gammaglobulin in neuromuscular and other diseases. Muscle Nerve 19:388-91, 1996.

    Lobo B, Greene WL. Indicate specific low-molecular-weight heparin product and dosage (letter). Chest 30:866, 1996.

    Shorr RI, Greene WL. A food-borne outbreak of expensive antibiotic use in a community teaching hospital (letter). JAMA 273:1908, 1995.

    Hoon TJ, Wood CA Jr, Whidden MA, Greene WL, Bottorf MB. The relative predictive performance of two theophylline pharmacokinetic dosing programs. Pharmacotherapy 8:82-88, 1988.

    Smith JL, Graham DY, Greene WL, Phelps SJ, Green B. Famotidine: a long-acting H-2 receptor antagonist. Comparison with cimetidine and ranitidine. Hosp Formul 22(suppl B):15-27, 1987.

    Greene WL. Calcium channel blockers in airway disease. US Pharmacist 11:H1-H16, 1986.

    Greene WL. Cimetidine drug interactions. Rev Drug Metab Drug Interact 5:25-51, 1984.

    Greene WL. Cimetidine in stress ulcer prophylaxis. Crit Care Med 12:571-75, 1984.

    Greene WL, Self TH, Levinson MJ. Cimetidine drug interactions. J Fam Practice 16:1087-93, 1983.


    Last update: February 2013